A Summary: Contrast-enhanced magnetic resonance imaging was used to produce high-resolution activation maps reflecting local changes in cerebral blood volume after a simple sensory stimulus, Activation of the forelimb region of the somatosen sory cortex was performed in a-chloralose-anaesthetized rats with an electrical stimulus (5 V, 3 Hz) delivered through needle electrodes placed subcutaneously on the left forelimb, A gra dient echo magnetic resonance imaging sequence, sensitive to Recovery of brain function and reorganization of sen sory and motor maps after deprivation of sensory input or local damage is an active area of neuroscience re search. Whereas it is recognized that the adult brain is able to undergo considerable plastic changes to affect restitution of function, much of the underlying neuro physiologic mechanisms remain unknown. The cortex of the rat provides a valuable model with which to study recovery of function. The cytoarchitecture is accurately documented, and its functional physiologic features are well characterized. Studies on this subject have relied on
changes in the relative amount of deoxyhemoglobin within the cerebral vasculature, produced a 4,05% ± 1.69% increase in signal intensity, This effect was enhanced with an injection of an intravascular iron oxide contrast agent (Combidex, Ad vanced Magnetics), resulting in a 9, II % ± 1.52% decrease in signal intensity. Key Words: Functional magnetic resonance imaging-Somatosensory activation-Iron oxide contrast agent-Cerebral blood volume-Combidex.
techniques that are either invasive (eg, involve electrode placement) or lack the spatial resolution necessary when working with laboratory animals. Recent developments in magnetic resonance (MR) imaging technology have allowed the spatial distribution of functional neuronal activity to be mapped noninvasively. Whereas most of these studies have been confined to human cognition (Kwong et aI., 1992; Bandettini et aI., 1992; Moseley and Glover, 1995) , functional magnetic resonance imaging (fMRI) provides an attractive alternative for functional mapping in the laboratory animal.
During somatosensory stimulation, local alteration in neuronal activity induces local changes in metabolism and CBF and volume (Fox and Raichle, 1986) . This re sults in a change in the local concentration of deoxyhe moglobin within the cerebral vasculature (Ogawa et aI., 1990; Turner et aI., 1991) and, because of the paramag netic properties of deoxyhemoglobin, causes a change in local T2 and T2* nuclear magnetic resonance relaxation time (Thulborn et aI., 1982) . This effect has been termed blood oxygenation level-dependent (BOLD) image con trast. Several studies have demonstrated the feasibility of performing fMRI in rats exploiting the BOLD effect (Kerskens et aI., 1996; Hyder et aI., 1994; Yang et aI., 1996; Scanley et aI., 1997; Gyngell et aI., 1996) . The HIGH-RESOLUTION FUNCTIONAL MRI OF RAT BRAIN I179 problem of working with anesthetized animals can partly be overcome with the use of a-chloralose, which is known to maintain cerebral vascular responses to sen sory stimuli. Even so, under these conditions the signal intensity changes observed by exploiting the BOLD ef fect typically are on the order of a few percentage points, and, as such, are vulnerable to changes in the basal physi ologic responses and can be obscured by noise and MR system instability. If functional brain mapping in labo ratory animals is to be a valuable adjunct to conventional neurophysiologic techniques, then a robust approach en abling high spatial resolution is required. The MR imag ing-detectable response associated with a functional task can be enhanced with the use of exogenous contrast agents (Villringer et aI., 1988; Rosen et aI., 1990) . Changes in local cerebral blood volume (CBV) associ ated with a sensory task can be mapped using dynamic MR imaging to follow the susceptibility-induced signal loss after the bolus injection of a suitable contrast agent (Belliveau et aI., 1991; Rosen et aI., 1990; Reimer et aI., 1995) . Although this approach has been used success fully in several fMRI studies in man, because of the need for rapid imaging, it is often inappropriate for laboratory experiments in which high-resolution of a small volume of tissue is required. Intravascular MR contrast agents, such as superparamagnetic iron oxide, with long half lives in the blood pool, provide an alternative approach for CBV mapping (Mandeville et aI., 1996; Berry et aI., 1996) . An increase in blood volume increases the con centration of the blood pool contrast agent (per unit vol ume of tissue) in the imaging slice and causes a local decrease in T2* and T2 (Ogawa et aI., 1990; Hamberg et aI., 1996; Mandeville et aI., 1996; Reimer et aI., 1995; Rosen et aI., 1990) . Although the change in blood vol ume is small compared with the blood flow response (Grubb et aI., 1974) , the large microvascular surface area causes a large change in the microscopic magnetic field gradients around the capillaries and small vessels, which in turn changes the degree of dephasing of the diffusing water proton spins (even far from the vessels and capil laries). It is this spin dephasing effect that is observed as a dramatic change in the T2 and T2* of the tissue vol ume.
Several ultrasmall superparamagnetic iron oxide (US PIO) colloids are in development for clinical use and have been used for contrast-enhanced MR imaging of liver, spleen, and lymph nodes in humans. One such agent, Combidex USPIO (Advanced Magnetics, Inc., Cambridge, MA, U.S.A.; Code 7227, AMI-227), which has a long blood half-life (Saini et aI., 1995) (more than 2 to 3 hours in rat), is suitable for contrast-enhanced CBV imaging. We report here on the use of Combidex to produce functional activation maps of the rat somatosen sory cortex associated with forelimb stimulation.
MATERIALS AND METHODS

Animal preparation
Male Sprague-Dawley rats (weighing 200 to 350 g) were anesthetized with isoflurane in oxygen (1.5% to 2%) for all surgical procedures. All experiments involving the use of ani mals were approved by Genentech's Animal Care and Use Committee (AAALAC accredited). The right femoral artery was cannulated for mean arterial blood pressure recording and blood sampling for blood gas measurements. The right femoral vein was cannulated for the administration of a-chloralose and contrast agent. After surgery, the anesthesia was switched to a-chloralose (80 mg/kg given intravenously in the initial dose; maintenance dose, 40 mg/kg at 90 minutes). Approximately 30 to 45 minutes was allowed after the initial bolus of a-chloralose before a successful fMRI experiment could be performed. Rats were allowed to breath spontaneously (oxygen, approximately 20% in air, adjusted to compensate for fluctuation in blood gases). The rats were placed in a purpose-built head holder (Applied Neuroscience, Thursod U.K.) and secured with ear bars. Fourteen animals were include in the fMRI study. Three additional rats were used to estimate a suitable dose of contrast agent.
Magnetic resonance imaging protocol
Magnetic resonance imaging experiments were performed on a 4.7-T Varian IN OVA system (Varian Associates, Palo Alto, CA, U.S.A.) using a single-surface coil (3-cm diameter) for all imaging experiments. Since it has previously been shown that for both the BOLD response (Menon et aI., 1993) and contrast-enhanced CBV-weighted imaging (de Crespigny et aI., 1997) that the optimal absolute change is obtained when the echo time (TE) is equal to the T2* of the tissue, all acti vation experiments were performed with TE = T2*. After global field inhomogeneity was reduced by shimming on the signal from the slice of interest, a series of gradient echo im ages were acquired at different TE to estimate T2* values from the rat cortex (TE: 10, 20, 30, 40, 50 milliseconds; other pa rameters include TR: 1 second, number of repetitions 4, field of view 30 mm 2 ). Multiple images were analyzed by a least square fitting procedure using MRVision software (Menlo Park, CA, U.S.A.). T2* in the cortex was estimated to be 45 millisec onds before contrast agent and the TE for the BOLD experiment was adjusted accordingly. After injection of contrast agent, a re duction in the T2* occurred in a dose-dependent manner. To es timate a suitable dose of Combidex for the CBV -weighted acti vation studies, the fMRI paradigm was repeated in three rats after incremental amounts of contrast agent to give the plasma doses quoted in Table I , and, assuming negligible washout over the experimental period (less than 45 minutes), the relative activation response was determined at each dose. A Combidex dose of approximately 6 mg Fe/kg body weight (in 500 fLL saline, intravenous bolus) was used for all subsequent studies. For the functional activation experiments, gradient echo images were acquired using a fast low-angle shot-based sequence (Haase, 1990) (TE 15 or 40 milliseconds; TR 70 milliseconds; field of view 30 mm 2 ; 23-degree flip angle; l.O-mm slice thickness; image acquisition matrix was 128 x 64 and zero-filled to 256 x 256; number of repetitions 2; giving an acquisition time of approximately 9 seconds per image). The higher resolution functional activation maps shown in Fig. 2 were acquired with the same parameters with the exception that the image acqui sition matrix was 256 x 128.
Functional activation paradigm
The fMRI activation paradigm consisted of an off-on-off sequence, with each period consisting of 10 images. A recovery period of at least 5 minutes was left between experiments. Forelimb stimulation was performed with a train of 3-to 5-V pulses with a 3-millisecond duration at 3 Hz, delivered using a pair of small needle electrodes inserted subcutaneously in the left forelimb. For reproducible stimulation, the electrodes were positioned such that digit motion was observed with the stimu lation mentioned earlier.
All image postprocessing was performed using the MRVi sion software. Activation maps were generated by calculating the correlation for each pixel between the idealized square stimulation function and the measured time course. Signal in tensity response was measured from the regions of activation, determined by eye from the cross-correlation maps. The ob served signal intensity changes were normalized to the mean signal intensity recorded from the baseline images before stimulation.
RESULTS AND DISCUSSION
Physiologic parameters were recorded at intervals dur ing the experiments and remained within an acceptable range (pH 7.25 to 7.45, Paco2 35 to 45 mm Hg, and Pao2 80 to 150 mm Hg). Two of 14 rats had persistent acidosis at the time of the fMRI experiment and were excluded The normalized signal intensity response for the BOLD effect is shown in Fig. lA . A significant increase in signal intensity of 4.05% ± 1.69% was seen (mean ± SD signal response recorded during activation compared with the mean preactivation, n = 6, P = 0.002). A reduction in T2* from 45 to 16 milliseconds measured from the cortex was seen after injection of Combidex (6 mg Fe/kg body weight). Repeating the activation para digm under these conditions resulted in a dramatic re duction in signal intensity during the stimulation period (Fig. IB) . Comparing the mean signal intensity before stimulation with the mean intensity during stimulation period gave a 9.11 % ± 1.52% reduction in signal inten sity (n = 6, P < 0.001). The coefficients of variation for the BOLD response and the CBV changes were 41.7% and 16.7%, respectively.
The changes in signal intensity seen on stimulation were more marked at higher doses of contrast agent ( Table 1 ). The response appeared to plateau at the top end of the concentration range used in this study, and no adverse side effects were associated with this dose. Higher doses of contrast agent may produce greater en hancement of the activation response but its effect on the physiologic state of the animal is uncertain.
To demonstrate the anatomical location of the regional changes seen from the CBV-weighted protocol, the fMRI experiment was repeated, but at higher resolution. Three consecutive activation experiments were performed in each plane, and activation maps were superimposed onto anatomical images (Fig. 2) . Discrete activation in the somatosensory cortex was observed, consistent with the with the following exception: echo time = 14 milliseconds. The signal intensity measured is normalized to the averaged baseline signal before stimulation. The thick line is the average response from the six rats with the data from each animal shown by thin lines. The stimulation period is shown by the bar.
Transverse Coronal
FIG. 2. Activation maps acquired after Combidex injection. The sagittal section was defined from a transverse conventional spin-echo sequence, centered 3 mm from the midline contralateral to the stimulated forelimb and including the forelimb area of the cortex, as indicated by the line diagram (outline of rat brain centered 0.48 mm from bregma; reproduced from Paxinos and Watson, 1996 , with permission from Academic Press, Inc.). The axial section was prescribed from the sagittal functional map as shown, and the transverse section was planned from the axial activation map. Functional magnetic resonance imaging parameters: repetition rate/echo time 70/14 milliseconds, field of view 30 mm, 23-degree flip angle, number of repetitions 4,256 x 128. Correlation maps were overlaid in color onto gradient echo images acquired with higher signal-to-noise (number of repetitions 16) for anatomical localization. To map the activated areas, a correlation map was generated between the idealized square stimulation function and the measured time course at each pixel position and displayed as a pseudocolor temperature scale superimposed on the anatomical image.
known tomographic location of the forelimb cortical rep resentation.
Recent theoretical and experimental work shows that the dependence of nuclear magnetic resonance transverse relaxation rate (R2 & R2*) on agent concentration is approximately linear (Fisel et aI., 1991; Berry et aI., 1996; Weisskoff et aI., 1994; Quast et aI., 1994) as functional activation. This is the ratio of LlR2* values before and during stimulation, and unknown constants of proportionality and Hct cancel from the equation (assum ing that they remain constant during activation). If the relative signal change from the initial contrast agent in jection is SrO and the relative signal change on activa tion is Sra (compared with preactivation, postinjection baseline), then the relative blood volume change on ac tivation can be estimated as follows:
This assumes negligible change in T2 * during the short time between contrast injection and the start of the activation scan. Using this formula for LlCBV, from the average "CBV" signal change on activation and the average signal change on Combidex injection (9.11 % ± 1.52% and 54% ± 14% at TE = 15 milliseconds, re spectively) the relative CBV change that occurs during activation can be estimated as 19 ± 6%. Unfortunately, it is difficult to compare this estimate to literature values because of a lack of similar published studies. It is in teresting to estimate the size of the competing BOLD effect at the same TE used for the CBV fMRI experi ments. The average BOLD signal increase of 4.05% at TE = 40 milliseconds is equivalent to a change in trans verse relaxation rate, LlR2* = -0.99 seconds-I . This translates into a 1.5% BOLD signal increase at TE = 15 milliseconds, compared with the 9.11 % signal decrease observed using the CBV effect, which suggests that our value of CBV change during activation is a slight under estimate as a result of the competing BOLD signal changes.
There are several potential advantages of using this approach over the BOLD response. The absolute signal intensity change is greater, resulting in improved con trast-to-noise ratio in the functional maps. The use of shorter TE would ultimately lead to more rapid acquisi tion (since TR can be reduced after the reduction in TE) for the gradient echo imaging sequence, or alternatively, an improvement in signal-to-noise ratio for the same ac quisition time by allowing, for example, the acquisition of two averages after halving the TR interval. In addi tion, a lower TE may render the imaging sequence less sensitive to a loss of phase coherence resulting from system phase instability. Shorter TEs reduce the sensi tivity of the imaging sequence to global macroscopic susceptibility artifacts that arise from interfaces of dif fering magnetic susceptibility outside of brain tissue (eg, skull and sinuses) but which may extend over a consid erable distance. This kind of distortion is prevalent in animal experiments because of the small, highly inhomo geneous samples and the fact that the work is done at higher magnetic field strengths. However, the signal response ob served in these studies contains contributions from J Cereb Blood Flow Metab, Vol. 18, No. 11, 1998 several different tissue compartments, both intravascular and extravascular, including capillary bed and larger ves sels. The relative contribution from each depends on fac tors such as vessel size and geometry, as well as the MR imaging protocol used, and several detailed studies have been performed to address these issues (Weisskoff et aI., 1994; Kennan et aI., 1994; van Zijl et aI., 1998) . The MR pulse sequences, such as spin-echo-based sequences with reasonable TE (eg, rapid acquisition with relaxation enhancement-based sequences [Hennig et aI., 1986] ), are more sensitive to small vessels and may produce better parenchymal localization (Bandettini et aI., 1994; Weis skoff et aI., 1994; Kennan et aI., 1994) . Further studies are required to fully establish the underlying mechanism responsible for the observed signal response and to op timize the experimental conditions for accurate CBV weighted fMRI of somatosensory function.
In conclusion, we have demonstrated that the local increase in CBV associated with somatosensory activa tion can be detected by MR imaging using steady-state magnetic susceptibility contrast agents. The signal re sponse observed occurs mainly as a result of a change in CBV and offers a robust approach for generating activa tion maps of cortical function in laboratory animals.
